Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_assertion type Assertion NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_head.
- NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_assertion description "[Not only do these studies offer the possibility for investigating the kinetic behavior of biochemically interesting mammalian AS mutants, but such ready access to large amounts of enzyme also represents a major step in the development and characterization of inhibitors that might have clinical utility in treating asparaginase-resistant ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_provenance.
- NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_assertion evidence source_evidence_literature NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_provenance.
- NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_assertion SIO_000772 16023613 NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_provenance.
- NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_assertion wasDerivedFrom befree-20150227 NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_provenance.
- NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_assertion wasGeneratedBy ECO_0000203 NP988602.RAgS46rVEBypVMa5t5bENcrssuGdDko2p18-2d95VgzB0130_provenance.